Trade

Acutaas Chemicals share price

High risk
  • 48%Low risk
  • 48%Moderate risk
  • 48%Balanced risk
  • 48%High risk
  • 48%Extreme risk
  • ₹2,728.00(0.12%)
    May 15, 2026 15:29:46 PM IST
    • NSE
    • BSE
  • Vol : 204.52 K (NSE + BSE)
    Last 20 day avg : 572.59 K

Acutaas Chemicals is trading 0.12% upper at Rs 2,728.00 as compared to its last closing price. Acutaas Chemicals has been trading in the price range of 2,784.75 & 2,701.10. Acutaas Chemicals has given 59.94% in this year & 0.04% in the last 5 days. Acutaas Chemicals has TTM P/E ratio 58.80 as compared to the sector P/E of 24.31.There are 6 analysts who have initiated coverage on Acutaas Chemicals. There are 2 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 131.76 Crores in its last quarter.Listed peers of Acutaas Chemicals include Solar Industries India (4.08%), Asian Paints (-0.65%), Coromandel International (0.39%).The Mutual Fund holding in Acutaas Chemicals was at 13.86% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Acutaas Chemicals was at 19.48% in 31 Mar 2026. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on May 16, 2026, 06:34 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.42
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.02
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.09
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.12
    Indicates Fair Valuation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
2,701.10
Highest
2,784.75
52 week range
Lowest
1,059.05
Highest
2,850.20
Acutaas Chemicals News
Acutaas Chemicals Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Solar Industries India
Bullish
17,351.604.081,57,026.0390.2625.760.089.52
Asian Paints
Bullish
2,606.00-0.652,49,966.9568.0113.770.907.13
Coromandel International
Bearish
1,865.000.3954,928.5739.156.370.505.40
SRF
Neutral
2,687.20-1.5779,613.0073.187.270.2516.14
Pidilite Industries
Bullish
1,466.45-1.181,49,241.6070.1715.090.692.26
Mutual Fund Ownership
View all
SBI Healthcare Opportunities Fund Regular Growth
NA
  • Amount Invested (Cr.) 117.63
  • % of AUM 3.19
Kotak Consumption Fund Regular Growth
NA
  • Amount Invested (Cr.) 36.64
  • % of AUM 2.94
Bank of India ELSS Tax Saver Fund Eco Growth
4/5
  • Amount Invested (Cr.) 37.39
  • % of AUM 2.67
Bank of India ELSS Tax Saver Fund Regular Growth
4/5
  • Amount Invested (Cr.) 37.39
  • % of AUM 2.67
Kotak Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 10.59
  • % of AUM 2.44
Acutaas Chemicals Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-04-30Audited Results & Final Dividend
2026-01-28Quarterly Results
2025-10-17Quarterly Results
2025-07-30Quarterly Results
2025-05-02Audited Results & Final Dividend
About the company Acutaas Chemicals
  • IndustryChemical Manufacturing
  • ISININE00FF01025
  • BSE Code543349
  • NSE CodeACUTAAS
Acutaas Chemicals Limited, formerly Ami Organics Limited, is a manufacturer of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 520 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas since inception and NCE across select high-growth high margin chronic therapeutic areas.
  • Management Info
  • Nareshkumar PatelExecutive Chairman of the Board and Managing Director
  • Bhavin ShahChief Financial Officer
  • Chetansinh ParmarChief Information Security Officer
  • Ekta SrivastavaCompany Secretary and Compliance Officer
  • Ram LokhandeWhole Time Director
  • Virendra MishraWhole Time Director
  • Chetankumar VaghasiaWhole Time Director
Acutaas Chemicals Share Price FAQs

Acutaas Chemicals is trading at 2728.00 as on Fri May 15 2026 09:59:46. This is 0.12% upper as compared to its previous closing price of 2724.80.

The market capitalization of Acutaas Chemicals is 22193.13 Cr as on Fri May 15 2026 09:59:46.

The average broker rating on Acutaas Chemicals is Buy. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 3 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Acutaas Chemicals is 2850.20 whereas the 52 wk low is 1059.05

Acutaas Chemicals can be analyzed on the following key metrics -

  • TTM P/E: 58.80
  • Sector P/E: 24.31
  • Dividend Yield: 0.09%
  • D/E ratio: 0.02

Acutaas Chemicals reported a net profit of 356.26 Cr in 2026.

The Mutual Fund Shareholding was 13.86% at the end of 31 Mar 2026.

Quick Links
EQUITY QUICK LINKS
Acutaas Chemicals QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Home/Market/Market Stats/  Acutaas Chemicals share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.